Results 181 to 190 of about 18,624 (215)

Health Status Outcomes after Computed Tomography or Invasive Coronary Angiography for Stable Chest Pain:A Prespecified Secondary Analysis of the DISCHARGE Randomized Clinical Trial

Importance: The effect of computed tomography (CT) vs invasive coronary angiography (ICA) on health status outcomes is unknown. Objective: To evaluate CT and ICA first-test strategies on quality of life (QOL) and angina. Design, Setting, and Participants:

core   +2 more sources

Psychometric properties of the EQ-5D-5L compared with EQ-5D-3L in cancer patients in Iran. [PDF]

Front Oncol, 2022
Moradi N, Poder TG, Safari H, Mojahedian MM, Ameri H.   +4 more
europepmc   +1 more source

Measuring health-related quality of life of patients with metastatic colorectal cancer using the Jordanian EQ-5D-3L value set: a cross-sectional observational study. [PDF]

BMJ Open
Al Habash K, Turfa R, Jaddoua S, Al Rabayah A.   +3 more
europepmc   +1 more source

Impact of disease activity on quality of life and EQ-5D-3L score in myasthenia gravis: results from the Swedish MG registry. [PDF]

J Neurol
Petersson M, Wu J, Berggren F, Schager I, Piehl F, Brauner S.   +5 more
europepmc   +1 more source

Health Perceptions and HRQL With Soft-Tissue Sarcoma at 12 Months Post-Op: Using the Wilson-Cleary Model to Evaluate the Measurement Properties of the RNLI and EQ-5D-3L. [PDF]

J Surg Oncol
Andersen NJ, Bergeron C, Turcotte R, Körner A.   +3 more
europepmc   +1 more source

Predicting EQ-5D-3L utility values from clinical data in a prospective cohort of kidney transplant recipients. [PDF]

Eur J Health Econ
Bonnemains V, Foucher Y, Tessier P, David C, Giral M, Dantan E, DIVAT Consortium.   +6 more
europepmc   +1 more source

Catalogues of EQ-5D-3L Health-Related Quality of Life Scores for 199 Chronic Conditions and Health Risks for Use in the UK and the USA. [PDF]

Pharmacoeconomics, 2023
Falk Hvidberg M, Hernández Alava M.
europepmc   +1 more source

Sacubitril/valsartan and quality of life assessed using the EuroQol Five-dimension Three-level questionnaire level sum score (EQ-5D-3L-LSS) in patients with HFrEF and HFmrEF/HFpEF. [PDF]

Eur Heart J Cardiovasc Pharmacother
Yang M, Henderson AD, Anand IS, Desai AS, Lam CSP, Maggioni AP, Martinez FA, Rouleau JL, Swedberg K, Vaduganathan M, van Veldhuisen DJ, Zannad F, Zile MR, Packer M, Rizkala A, Lewis EF, Jhund PS, Solomon SD, McMurray JJV.   +18 more
europepmc   +1 more source

Adjusting Health State Utility Values for Multiple Conditions: Real-World EQ-5D-3L Data Modeling in Brazil. [PDF]

Pharmacoecon Open
da Costa MR, Dos Santos Júnior B, da Silva Santos M.   +2 more
europepmc   +1 more source

Estimating the Relationship Between EQ-5D-5L and EQ-5D-3L: Results from a UK Population Study. [PDF]

Pharmacoeconomics, 2023
Hernández Alava M, Pudney S, Wailoo A.
europepmc   +1 more source